API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/pharma/leo-scores-again-hand-eczema-its-jak-inhibitor-cream
https://www.fiercepharma.com/pharma/leo-pharmas-jak-cream-posts-significant-win-hand-eczema-potential-brawl-incytes-opzelura
https://www.fiercepharma.com/pharma/leo-pharmas-topical-jak-touts-promising-phase-3-data-chronic-hand-eczema
https://www.businesswire.com/news/home/20230209005440/en/LEO-Pharma-Announces-Positive-Phase-3-Topline-Results-From-DELTA-2-Trial-With-Delgocitinib-Cream-in-Adults-With-Moderate-to-Severe-Chronic-Hand-Eczema-CHE-Confirming-the-Positive-Results-of-the-Recent-DELTA-1-Trial